Skip to main content

Kazimi A J's Form 4 filing

Cumberland Pharmaceuticals Inc (CPIX) · filed Nov 5, 2024

Accession no.
0001628280-24-045329
Filed
Nov 5, 2024
Trade date
Oct 1-31, 2024
Filing delay
35 daysLate
Rule 10b5-1 plan
Checked

This filing lists 23 non-derivative transactions and 0 derivative transactions. Open-market purchases total $1.83K. It was filed 35 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Kazimi A JCIK 0001075050Director, Officer (Chairman and CEO), 10% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Oct 1, 2024Common StockPPurchaseAcquired+62$1.27+$78.745,698,657Direct
Oct 2, 2024Common StockPPurchaseAcquired+62$1.29+$79.985,698,719Direct
Oct 3, 2024Common StockPPurchaseAcquired+62$1.28+$79.365,698,781Direct
Oct 4, 2024Common StockPPurchaseAcquired+62$1.28+$79.365,698,843Direct
Oct 7, 2024Common StockPPurchaseAcquired+62$1.29+$79.985,698,905Direct
Oct 8, 2024Common StockPPurchaseAcquired+62$1.30+$80.65,698,967Direct
Oct 9, 2024Common StockPPurchaseAcquired+62$1.31+$81.225,699,029Direct
Oct 10, 2024Common StockPPurchaseAcquired+62$1.32+$81.845,699,091Direct
Oct 11, 2024Common StockPPurchaseAcquired+62$1.39+$86.185,699,153Direct
Oct 14, 2024Common StockPPurchaseAcquired+62$1.37+$84.945,699,215Direct
Oct 15, 2024Common StockPPurchaseAcquired+62$1.30+$80.65,699,277Direct
Oct 16, 2024Common StockPPurchaseAcquired+62$1.25+$77.55,699,339Direct
Oct 17, 2024Common StockPPurchaseAcquired+62$1.30+$80.65,699,401Direct
Oct 18, 2024Common StockPPurchaseAcquired+62$1.28+$79.365,699,463Direct
Oct 21, 2024Common StockPPurchaseAcquired+62$1.25+$77.55,699,525Direct
Oct 22, 2024Common StockPPurchaseAcquired+62$1.25+$77.55,699,587Direct
Oct 23, 2024Common StockPPurchaseAcquired+62$1.26+$78.125,699,649Direct
Oct 24, 2024Common StockPPurchaseAcquired+62$1.24+$76.885,699,711Direct
Oct 25, 2024Common StockPPurchaseAcquired+62$1.23+$76.265,699,773Direct
Oct 28, 2024Common StockPPurchaseAcquired+62$1.25+$77.55,699,835Direct
Oct 29, 2024Common StockPPurchaseAcquired+62$1.24+$76.885,699,897Direct
Oct 30, 2024Common StockPPurchaseAcquired+62$1.32+$81.845,699,959Direct
Oct 31, 2024Common StockPPurchaseAcquired+62$1.20+$74.45,700,021Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)